kabutan

Watahan & Co.,Ltd.(3199) Summary

3199
TSE Prime
Watahan & Co.,Ltd.
1,427
JPY
-11
(-0.76%)
Dec 5, 12:49 pm JST
9.19
USD
Dec 4, 10:49 pm EST
Result
PTS
outside of trading hours
1,432.9
Dec 5, 9:51 am JST
Summary Chart Historical News Financial Result
PER
12.0
PBR
1.15
Yield
2.10%
Margin Trading Ratio
25.39
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,436 JPY 9.25 USD
Previous Close Dec 4
1,438 JPY 9.25 USD
High Dec 5, 9:00 am
1,436 JPY 9.25 USD
Low Dec 5, 12:37 pm
1,423 JPY 9.17 USD
Volume
18,800
Trading Value
0.03B JPY 0.17M USD
VWAP
1429.37 JPY 9.21 USD
Minimum Trading Value
142,700 JPY 919 USD
Market Cap
0.03T JPY 0.18B USD
Number of Trades
76
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
96
1-Year High Oct 28, 2025
371
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 11,200 23,400 2.09
Nov 21, 2025 10,200 28,100 2.75
Nov 14, 2025 4,800 31,400 6.54
Nov 7, 2025 4,400 35,500 8.07
Oct 31, 2025 4,800 35,900 7.48
Company Profile
Watahan & Co.,Ltd. operates home centers primarily in Nagano Prefecture, handling food products including some fresh items. The company is also involved in roof renovation and trading businesses.
Sector
Retail Trade
Watahan & Co.,Ltd. focuses on three main business segments: retail, construction, and trading. In the retail segment, the company operates various store formats centered around supercenters, offering a wide range of products from fresh food to home center merchandise. The company pursues low prices and freshness through its EDLP strategy and direct procurement. It also operates multiple e-commerce platforms. The construction segment covers a wide range of services, including wooden construction, steel frame building, interior and exterior work, and the construction of automated multi-story parking facilities. The company's strengths lie in its proprietary construction methods and integrated in-house production system. In the trading segment, Watahan imports and sells pharmaceutical and chemical raw materials, and manufactures active pharmaceutical ingredients for fertility treatments. Additionally, the company engages in comprehensive building management and real estate transactions.